We’re pleased to announce official approval on our genetics from the Instituto Colombiano Agropecuario (ICA) in Colombia!
The official approval of five of Green Point Research’s CBD seeds, when combined with our seed import/export/production license and non-psychoactive cultivation license, allows us to begin genetic and commercial production of our non-psychoactive cannabis in the Andean region of Colombia. We now begin our testing for approvals in the Ibague region at our facility in Tolima. Colombia’s tropical climate and diverse geography make it an ideal location to breed seeds that resist fungal diseases. We look forward to cultivating a better future with our Colombian partners.
Read more about the fast-growing hemp market in Colombia in Hemp Industry Daily’s recent article: https://hempindustrydaily.com/
About Green Point Research
Green Point Research (GPR) is a vertically integrated phytocannabinoid-rich hemp biomass originator and processor founded in 2016. GPR controls its supply chain from seed to processing bulk cannabinoids for business to business sale. Satividol, a cannabidiol (CBD) softgel, is among the products the company produces. Contact Green Point Research at 954-500-HEMP to learn more about the Green Point Method and how to purchase seeds, seed starts, and clones. For more information, please visit www.greenpointhemp.com.
RETURN TO NEWS